New Customers Get 10% Off – Use Code: LUX10

Cellular Peptide

DSIP

5.0 Reviews

Delta-Sleep PeptideEmideltide

A 9-amino acid peptide that regulates delta-wave sleep patterns and circadian rhythm signaling, investigated for its role in sleep onset mechanisms in research models. Premium Research Peptide.

Original price was: $59.99.Current price is: $53.99.

2 Day FAST Shipping

99%+ Purity Tests

Ships from USA

USA Lab Tested

We accept :

Certificate of Analysis

Third Party Tested by Freedom Diagnostics

How DSIP Works

The Science, Simplified

Natural Sleep Programming

DSIP is a 9-amino acid nonapeptide synthesized in the hypothalamus. Unlike traditional sedatives that “force” unconsciousness, DSIP modulates circadian rhythms and delta-wave sleep architecture, promoting a natural sleep onset mechanism.
Key insight: In research, DSIP has been shown to increase total sleep time by 59% within 130 minutes of administration in healthy models. It functions by normalizing disturbed sleep patterns, with effects that often persist for days after a single dosing event.
GE
Primary

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

COL
Strongest

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

Cu²⁺
Supportive

Gene Expression

Epigenetic Modulation

Upregulates 59% of affected genes Activates 47 DNA repair genes Suppresses inflammatory pathways

HPA Axis & Stress Response

DSIP targets the Hypothalamic-Pituitary-Adrenal (HPA) axis, which is the body's central stress response system. It acts to attenuate the physiological and emotional responses to chronic stress.

Key insight: By reducing cortisol secretion and improving stress-coping mechanisms, DSIP supports emotional stability. This makes it a primary subject for studies involving high-stress environments and recovery from psychological burnout.

Pain Modulation & Opioid Interaction

DSIP interacts with the endogenous opioid system, influencing pain perception and antinociceptive thresholds.

Key insight: Clinical studies have shown an 86% response rate for pain reduction in chronic pain subjects. Interestingly, its pain-relieving effects can be blocked by naloxone, indicating a direct involvement with opioid receptors, which has led to significant research into its role in managing withdrawal symptoms.

Wrinkle Reduction Comparison

Safety Profile from Research

What clinical studies report

DSIP is characterized by an exceptional safety profile, largely due to its status as an endogenous peptide that is even naturally present in human breast milk.

🧿 Common Digestive Issues

15%

Headache

mild

10%

Nausea

mild

8%

Vertigo

mild

Safety Advantage

No Determined LD50

📊 Discontinuation Rates

🚫 Trial Exclusions

⚡ Regulatory Status

💡 Researcher Notes

Compound Information

Technical specifications for each component

🔬 Molecular Profile

What Is DSIP?

Type

Synthetic nonapeptide

CAS Number

62568-57-4

Molecular Formula

C35H48N10O15

Molecular Weight

848.8 g/mol

Amino Acids

9 residues

Sequence

Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu

🧊 Storage Requirements

Stability Information

First isolated from rabbit brain in 1977 by Schoenenberger & Monnier

Lyophilized (powder)

-20°C

protect from light

Reconstituted

2-8°C

use within 24 hours

Stability

15 minutes (plasma half-life)

if kept frozen and sealed.

📊 Physical Properties

Development History

First isolated from rabbit brain in 1977 by Schoenenberger & Monnier

Discovery

1977, Switzerland

Discoverers

Schoenenberger & Monnier

Origin

Rabbit mesodiencephalic ventricle

INN Name

Emideltide

Human Studies

1980s-present

Regulatory Status

Research compound

Frequently Asked Questions

Common questions about DSIP

Technically, no. Sedatives force the brain into a state of unconsciousness, often skipping critical sleep stages like REM or Deep (Delta) sleep. DSIP acts more like a "sleep programmer," encouraging the brain to enter natural, restorative delta-wave sleep on its own
Because DSIP interacts with opioid receptors and the HPA axis, it can help "re-regulate" a system that has been disrupted by chronic substance use. Research shows a 97% symptom relief rate in opiate withdrawal models, significantly reducing the intensity of symptoms.
In research, one of the most interesting properties of DSIP is its "long-tail" effect. A single administration can sometimes normalize sleep patterns for several nights afterward, suggesting it helps reset the body’s internal clock rather than just providing a one-time sleep effect.
While it is primarily associated with sleep, DSIP’s ability to lower cortisol and modulate the stress response makes it a candidate for studying daytime anxiety and stress resilience without the risk of daytime drowsiness.
No. It has been extensively studied in humans since the late 1970s, but it remains an investigational research compound. It is sold strictly for laboratory use and is not intended for human consumption or medical treatment.

Sources & References

Peer-reviewed research

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.